News
LDC’s Aziz Ul-Haq recognised in HealthInvestor Power List
6 Nov 2025
LDC Partner Aziz Ul-Haq has been named a finalist in HealthInvestor’s Power List for 2025. This is the second consecutive year that Aziz has been recognised.
The 16th annual list, compiled by leading trade publication HealthInvestor UK, honours the most effective, inspiring and influential leaders in the health and social care sectors.
Aziz has been named in the Equity Investor category, which recognises those who have made significant, impactful investments in healthcare businesses and deployed a successful investment strategy to maximise returns across a varied portfolio.
Aziz’s inclusion follows a successful year for LDC in the healthcare sector with a number of new investments, including backing the management team of Panthera Biopartners, the UK’s largest Site Management Organisation for commercial clinical trials. LDC was also named Private Equity Investor of the Year at the 2025 HealthInvestor Awards.
LDC has decades of experience supporting management teams in healthcare services, pharma services, and MedTech & devices. In the last decade, we’ve invested over £400m in 18 healthcare businesses, and in the same period grew average revenues for exited businesses by 193%.
The overall winners of all the 2025 categories, including Equity Investor, will be announced at the HealthInvestor Power List Awards at the London Marriott on 3rd December.
LDC extends its congratulations to all of those who have been named finalists in this year’s HealthInvestor Power List. You can see the full list here.
